Results 191 to 200 of about 78,093 (211)

Randomized, Open-Label Phase 3 Study Evaluating Immunogenicity, Safety, and Reactogenicity of RSVPreF3 OA Coadministered with FLU-QIV-HD in Adults Aged ≥ 65. [PDF]

open access: yesInfect Dis Ther
Buynak R   +11 more
europepmc   +1 more source

Identification of minimal residual disease using the clonesight test for ultrasensitive ctDNA detection to anticipate late relapse in early breast cancer. [PDF]

open access: yesBreast Cancer Res
Comino-Méndez I   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy